Company profile
Elucid
Plaque detection is just the beginning
- Industry
- Medical Equipment Manufacturing
- Employees
- 143
- Headquarters
- Boston, Massachusetts
- Founded
- 2013
- LinkedIn followers
- 12,081
- Office locations
- 1
Elucid company summary
Elucid is a company in the Medical Equipment Manufacturing industry, headquartered in Boston, Massachusetts, founded in 2013. On LinkedIn the company has around 143 employees and 12,081 followers. Its listed specialties include cardiovascular, plaque characterization, FFRct, CCTA, Heart Disease.
What technology does Elucid use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Elucid
Elucid is a Boston-based medical technology company using histology-validated software to provide physicians with a cost-effective means to optimize treatment decisions for patients with cardiovascular disease. Advanced clinical insight from Elucid's CTA analysis equips physicians with critical information designed to enable precision medicine. Elucid is the first non-invasive software to quantify atherosclerotic plaque characteristics compared to histopathology, including Lipid Rich Necrotic Core. The company has published studies for its derivation of fractional flow reserve (FFRct) based on the vasodilative capacity of the vessel wall. Elucid's unique information informs improved treatment decisions by physicians leading to better patient outcomes, improved quality of care, and reduced healthcare costs.
Specialties
Where is Elucid located?
Elucid lists 1 location.
Compare companies similar to Elucid
More companies in Medical Equipment Manufacturing.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Elucid elucid.com | Medical Equipment Manufacturing | 143 | 2013 | Boston, Massachusetts |
Boston Scientific bostonscientific.com | Medical Equipment Manufacturing | 54,970 | - | Marlborough, MA |
BD bd.com | Medical Equipment Manufacturing | 46,224 | - | Franklin Lakes, New Jersey |
Baxter International Inc. baxter.com | Medical Equipment Manufacturing | 39,218 | - | Deerfield, Illinois |
Alcon alcon.com | Medical Equipment Manufacturing | 27,667 | - | Geneva, Switzerland |
Smith+Nephew smith-nephew.com | Medical Equipment Manufacturing | 19,271 | - | Watford, Hertfordshire, GB |
Zimmer Biomet EMEA zimmerbiomet.com | Medical Equipment Manufacturing | 19,125 | - | Warsaw, Indiana |
Olympus Corporation olympus-global.com | Medical Equipment Manufacturing | 13,703 | 1919 | Shinjuku-ku, Tokyo |
Intuitive intuitive.com | Medical Equipment Manufacturing | 13,091 | 1995 | California, 94086 |
Medline Australia medline.com | Medical Equipment Manufacturing | 18,899 | - | Northfield, IL |
Edwards Lifesciences edwards.com | Medical Equipment Manufacturing | 14,197 | 1958 | Irvine, CA |
Frequently asked questions about Elucid
What does Elucid do?
Elucid is a Boston-based medical technology company using histology-validated software to provide physicians with a cost-effective means to optimize treatment decisions for patients with cardiovascular disease. Advanced clinical insight from Elucid's CTA analysis equips physicians with critical information designed to enable precision medicine. Elucid is the first non-invasive software to quantify atherosclerotic plaque characteristics compared to histopathology, including Lipid Rich Necrotic Core. The company has published studies for its derivation of fractional flow reserve (FFRct) based on the vasodilative capacity of the vessel wall. Elucid's unique information informs improved treatment decisions by physicians leading to better patient outcomes, improved quality of care, and reduced healthcare costs.
How many employees does Elucid have?
Elucid has around 143 employees on LinkedIn.
Where is Elucid headquartered?
Elucid is headquartered in Boston, Massachusetts.
When was Elucid founded?
Elucid was founded in 2013.
Build a lead list from companies like Elucid
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.